A Case-control Study on Insulin Resistance, Metabolic Co-variates & Prediction Score in Non-alcoholic Fatty Liver Disease
Overview
Affiliations
Background & Objective: Asian Indians have a high prevalence of insulin resistance and the metabolic syndrome. Currently, non-alcoholic fatty liver disease (NAFLD) is considered to be an integral part of the metabolic syndrome with insulin resistance as a central pathogenic factor. We studied anthropometric parameters, insulin resistance and metabolic co-variates in subjects with NAFLD as compared to those without NAFLD, and also developed a prediction score for NAFLD.
Methods: Thirty nine subjects with NAFLD and 82 controls were selected for the study after ultrasonography of 121 consecutive apparently healthy subjects. Anthropometric profile [body mass index (BMI), waist circumference (WC) etc,], lipid profile, hepatic aminotransferases, fasting blood glucose (FBG), insulin were recorded and value of homeostasis model assessment of insulin resistance (HOMA-IR) was analysed. Step-wise logistic regression analysis and area under the receiver operator curve (aROC) were analysed to arrive at a prediction score.
Results: Overall, prevalence of NAFLD was 32.2 per cent and prevalence of metabolic syndrome was seen in 41 per cent among cases and 19.5 per cent in controls (P<0.01). Subjects with NAFLD had significantly higher values of BMI, WC, hip circumference, FBG, fasting insulin, total cholesterol and serum triglycerides. Step-wise logistic regression analysis showed odds ratio (OR) and 95 per cent confidence interval (CI) for BMI [ 4.3 (1.6, 11.3)], FBG [5.5 (1.5, 19.8)] and fasting insulin [ 2.4 (1.0, 5.8)] as independent predictors of NAFLD. The prediction score for NAFLD was; 1 (fasting insulin) +1.6 (BMI) + 1.9 (FBG) (sensitivity of 84.6%, specificity of 51.2% and aROC 76%).
Interpretation & Conclusion: In this study, presence of NAFLD indicated close relationship with multiple features of metabolic syndrome. The prediction score developed could be used as a screening tool to predict NAFLD among Asian Indians in north India.
Mehta M, Shah J, Joshi U Cureus. 2024; 16(10):e70768.
PMID: 39364176 PMC: 11448744. DOI: 10.7759/cureus.70768.
Duseja A, Singh S, De A, Madan K, Rao P, Shukla A J Clin Exp Hepatol. 2023; 13(2):273-302.
PMID: 36950481 PMC: 10025685. DOI: 10.1016/j.jceh.2022.11.014.
Singhai A, Yadav V, Joshi R, Malik R, T S, Kamle S Cureus. 2023; 15(1):e33977.
PMID: 36820120 PMC: 9938792. DOI: 10.7759/cureus.33977.
New born macrosomia in gestational diabetes mellitus.
Bernea E, Uyy E, Mihai D, Ceausu I, Ionescu-Tirgoviste C, Suica V Exp Ther Med. 2022; 24(6):710.
PMID: 36382102 PMC: 9634345. DOI: 10.3892/etm.2022.11646.
A study of non-alcoholic fatty liver disease-liver fat score in overweight and obese individuals.
Koneru K, Bhatt V, Kakrani A, Edara M, Reddy V, Jawade P J Family Med Prim Care. 2022; 11(8):4368-4374.
PMID: 36352921 PMC: 9638680. DOI: 10.4103/jfmpc.jfmpc_58_22.